Clinical and laboratory features of Macedonian children with OCRL mutations.
OCRL mutations, which are a hallmark of Lowe syndrome, have recently been found in patients with isolated renal phenotype (Dent-2 disease). In this report, we describe clinical and laboratory features in five Macedonian children with mutations in the OCRL gene. Children with a clinical diagnosis of Lowe syndrome or Dent disease underwent complete neurological and ophthalmological examination, imaging of the kidney and urinary tract, assessment of renal tubular function, and mutation analysis of the OCRL gene. Two children (18 months and 11 years, respectively) were diagnosed with Lowe syndrome on the basis of congenital cataracts, severe psychomotor retardation, and renal dysfunction. Both children had low molecular weight proteinuria (LMWP) and hypercalciuria, but not Fanconi syndrome. The older one had bilateral nephrolithiasis due to associated hypocitraturia and mild hyperoxaluria. Three children with asymptomatic proteinuria were diagnosed with Dent-2 disease; none had cataracts or neurological deficit. One child showed mild mental retardation. All had LMWP, hypercalciuria, and elevated enzymes (creatine phosphokinase, lactic dehydrogenase). All three children had an abnormal Tc-99m DMSA scan revealing poor visualization of the kidneys with a high radionuclide content in the bladder; none had nephrolithiasis or nephrocalcinosis. In conclusion, children with OCRL mutations may present with very mild phenotype (asymptomatic proteinuria with/without mild mental retardation) or severe classic oculocerebrorenal syndrome of Lowe. Elevated enzymes and abnormal results on the Tc-99m DMSA scan may be useful indicators for Dent-2 disease.
University Children's Hospital, Medical School Skopje, Skopje, Macedonia. vtasic2003@gmail.com
Velibor
V
Tasic
Vladimir J
VJ
Lozanovski
Petar
P
Korneti
Nadica
N
Ristoska-Bojkovska
Vesna
V
Sabolic-Avramovska
Zoran
Z
Gucev
Michael
M
Ludwig
D002648:Child; D004252:DNA Mutational Analysis; D057973:Dent Disease / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007223:Infant; D009800:Oculocerebrorenal Syndrome / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics*; D018843:Republic of North Macedonia
D010744:Phosphoric Monoester Hydrolases; C075695:OCRL protein, human
AMA Am J Dis Child. 1952 Feb;83(2):164-84
14884753
Nephron. 1999 Jan;81(1):49-54
9884419
Am J Hum Genet. 2005 Feb;76(2):260-7
15627218
Nephrol Dial Transplant. 2003 Sep;18(9):1923-5
12937245
Clin Nucl Med. 1995 Mar;20(3):215-9
7750213
N Engl J Med. 1991 May 9;324(19):1318-25
2017228
Nephron Physiol. 2009;112(2):p27-36
19390221
Am J Kidney Dis. 2006 Dec;48(6):942.e1-14
17162149
J Pediatr. 2009 Jul;155(1):94-9
19559295
Mol Genet Metab. 2000 Mar;69(3):213-22
10767176
J Pediatr. 1997 Aug;131(2):252-7
9290612
J Clin Invest. 1998 May 15;101(10):2042-53
9593760
Pediatr Nephrol. 1996 Apr;10(2):167-70
8703703
Pediatr Nephrol. 2009 Nov;24(11):2211-6
19579036
Mol Biol Cell. 2005 Aug;16(8):3467-79
15917292
Nephrol Dial Transplant. 2006 Oct;21(10):2708-17
16861240
Pediatr Nephrol. 2008 Feb;23(2):243-9
18038239
Am J Kidney Dis. 2004 Mar;43(3):538-43
14981612
Dev Cell. 2007 Sep;13(3):377-90
17765681
J Nucl Med. 1989 Jul;30(7):1219-23
2544699
Eur J Nucl Med. 1983;8(9):404-5
6313371
Pediatr Nephrol. 2009 Dec;24(12):2369-73
19806368
Arch Ophthalmol. 2003 Sep;121(9):1234-7
12963605
Pediatr Nephrol. 2007 Jul;22(7):975-80
17384968
Ann Nucl Med. 2002 Nov;16(7):499-501
12508844
Pediatr Nephrol. 2009 Oct;24(10):1967-73
19582483
Pediatr Nephrol. 2010 Apr;25(4):781-2
19902262
Clin J Am Soc Nephrol. 2008 Sep;3(5):1430-6
18480301